Bio-Techne Corporation (TECH)
After hours:
| Previous close | 71.49 |
| Open | 71.97 |
| Bid | 72.08 x 100 |
| Ask | 72.16 x 100 |
| Day's range | 71.57 - 72.74 |
| 52-week range | 51.79 - 85.57 |
| Volume | |
| Avg. volume | 977,133 |
| Market cap | 11.433B |
| Beta (5Y monthly) | 1.27 |
| PE ratio (TTM) | 68.66 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.32 (0.45%) |
| Ex-dividend date | 19 Aug 2024 |
| 1y target est | N/A |
- PR Newswire
ScaleReady announces the inaugural G-Rex® Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine
ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that Dr. Steve Feldman, Scientific Director and Site Head of Stanford Medicine's Laboratory for Cell and Gene Medicine (LCGM), has been awarded the inaugural G-Rex® Grant. Dr. Feldman's $300,000 G-Rex Grant will enable expeditious development of Stanford Medicine's LCGM's G-Rex platform for CAR-T cell therapy manufacturing, which will be offered to internal investig
- PR Newswire
BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor conferences:
- PR Newswire
BIO-TECHNE DECLARES DIVIDEND
Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2024. The quarterly dividend will be payable August 30, 2024, to all common shareholders of record on August 19, 2024. Future cash dividends will be considered by the Board of Directors on a quarterly basis.
